1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow anacetrapib: new trials by email Literature Review of anacetrapib trials Research Report on anacetrapib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029) anacetrapib, Comparator: atorvastatin, Comparator: Placebo - Dyslipidemia | Phase 2 | Completed | Merck Sharp & Dohme LLC | 408 | 2009-09-01 | 2015-05-06 |
| MK0859 Dose-Ranging Study (0859-003) MK0859 - Hypercholesterolemia, Mixed Hyperlipemia | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 500 | 2006-06-01 | 2015-03-02 |
Dyslipidemias (1) · Hypercholesterolemia (1) · Hyperlipoproteinemia Type V (1)